Skip to main content

REGENXBIO Inc.

RGNX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001590877

In the last 90 days, REGENXBIO Inc. insiders filed 1 open-market purchase and 0 sales; 165 institutions reported holding it in 13F filings for Q2 2026, worth $504.6M in total; no superinvestor holds it.

Q2 2026 vs. Q1 2026

How the institutions holding REGENXBIO Inc. changed between Q1 2026 and Q2 2026.

All holders in Q2 2026All holders in Q1 2026

13F holders of RGNX: Q1 2026 compared with Q2 2026
MeasureQ1 2026Of which not filed for Q2 2026Q2 2026Change
Holders1782165−11
Shares42.6M72.2K42.2M−332.2K (−0.8%)
Value$355.1M$604.8K$504.6M+$150.1M (+42.3%)

2 institutions that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so the changes leave them out.

New holders (24)

Institutions that held REGENXBIO Inc. at the end of Q2 2026 but not at the end of Q1 2026.

Institutions new to RGNX in Q2 2026
InstitutionSharesValue% of portfolio
Marshall Wace, LLP1,284,950$15.4M0.01%
Citadel Advisors LLC669,023$8.01M0.00%
Lazard Asset Management LLC370,375$4.44M0.01%
CI Private Wealth, LLC217,661$2.61M0.00%
Walleye Capital LLC203,726$2.44M0.01%
Schroder Investment Management Group91,481$1.08M0.00%
Trexquant Investment LP86,420$1.04M0.01%
Simplex Trading, LLC49,244$589.9K0.02%
NewEdge Wealth, LLC47,700$571.4K0.01%
Aquatic Capital Management LLC43,998$527.1K0.02%
Winton Group Ltd24,200$289.9K0.01%
Gsa Capital Partners LLP22,607$271.0K0.02%
PEAK6 LLC22,000$263.6K0.01%
Axq Capital, LP18,446$221.0K0.02%
Quadrature Capital Ltd16,277$195.0K0.00%
Almanack Investment Partners, LLC.13,955$167.2K0.02%
Inscription Capital, LLC10,367$124.2K0.01%
Quantbot Technologies LP4,230$50.7K0.00%
Pacer Advisors, Inc.909$11.0K0.00%
Quarry LP164$1.97K0.00%
Action Point Financial Planning, LLC118$1.41K0.00%
Clearstead Advisors, LLC84$1.01K0.00%
Bogart Wealth, LLC50$5990.00%
Global Retirement Partners, LLC22$2640.00%

Sold out (35)

Institutions that held REGENXBIO Inc. at the end of Q1 2026 and filed for Q2 2026 without it.

Not filed for Q2 2026 yet (2)

Institutions that held REGENXBIO Inc. at the end of Q1 2026 and haven't filed a 13F for Q2 2026. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding RGNX in Q1 2026 that haven't filed for Q2 2026
InstitutionShares, Q1 2026Value, Q1 2026
CWM, LLC72,115$604.3K
Sunbelt Securities, Inc.55$461